ID   MA-160
AC   CVCL_8261
SY   MA 160; MA160; Microbiological Associates-160
DR   BioSample; SAMN03151741
DR   Wikidata; Q54903695
RX   CelloPub=CLPUB00262;
RX   DOI=10.1007/978-1-4757-1647-4_13;
RX   PubMed=66218;
RX   PubMed=87387;
RX   PubMed=93571;
RX   PubMed=535908;
RX   PubMed=1246601;
RX   PubMed=4319198;
RX   PubMed=4469665;
RX   PubMed=6451928;
RX   PubMed=20143388;
WW   https://iclac.org/wp-content/uploads/Cross-Contaminations_v12_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=66218; PubMed=93571; PubMed=1246601; PubMed=4469665; PubMed=6451928; PubMed=20143388). Originally thought to originate from a benign prostatic hyperplasia biopsy from Monroe Vincent one of the authors of the original paper.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00026.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 22
//
RX   CelloPub=CLPUB00262;
RA   Gold M.;
RT   "A conspiracy of cells. One woman's immortal legacy and the medical
RT   scandal it caused.";
RL   (In) ISBN 9780887060991; pp.1-171; State University of New York Press; Albany (1986).
//
RX   DOI=10.1007/978-1-4757-1647-4_13;
RA   Biedler J.L.;
RT   "Chromosome abnormalities in human tumor cells in culture.";
RL   (In) Human tumor cells in vitro; Fogh J. (eds.); pp.359-394; Springer; New York (1975).
//
RX   PubMed=66218;
RA   Webber M.M., Horan P.K., Bouldin T.R.;
RT   "Present status of MA-160 cell line. Prostatic epithelium or HeLa
RT   cells.";
RL   Invest. Urol. 14:335-343(1977).
//
RX   PubMed=87387;
RA   Pontes J.E., Choe B., Rose N., Pierce J.M. Jr.;
RT   "Immunochemical identification of prostatic epithelial cells in
RT   culture.";
RL   Invest. Urol. 16:483-485(1979).
//
RX   PubMed=93571; DOI=10.1007/BF02618148;
RA   Pontes J.E., Pierce J.M. Jr., Choe B.-K., Rose N.R.;
RT   "MA 160 and EB33 cell lines: HeLa cell contaminants, hybrids or
RT   prostatic epithelial cells?";
RL   In Vitro 15:469-472(1979).
//
RX   PubMed=535908; DOI=10.1007/BF02619151;
RA   Nelson-Rees W.A.;
RT   "Prostatic acid phosphatase in cell lines MA 160, EB33 and HeLa
RT   cells.";
RL   In Vitro 15:935-935(1979).
//
RX   PubMed=1246601; DOI=10.1126/science.1246601;
RA   Nelson-Rees W.A., Flandermeyer R.R.;
RT   "HeLa cultures defined.";
RL   Science 191:96-98(1976).
//
RX   PubMed=4319198; DOI=10.1126/science.170.3957.540;
RA   Fraley E.E., Ecker S., Vincent M.M.;
RT   "Spontaneous in vitro neoplastic transformation of adult human
RT   prostatic epithelium.";
RL   Science 170:540-542(1970).
//
RX   PubMed=4469665; DOI=10.1126/science.184.4141.1093;
RA   Nelson-Rees W.A., Flandermeyer R.R., Hawthorne P.K.;
RT   "Banded marker chromosomes as indicators of intraspecies cellular
RT   contamination.";
RL   Science 184:1093-1096(1974).
//
RX   PubMed=6451928; DOI=10.1126/science.6451928;
RA   Nelson-Rees W.A., Daniels D.W., Flandermeyer R.R.;
RT   "Cross-contamination of cells in culture.";
RL   Science 212:446-452(1981).
//
RX   PubMed=20143388; DOI=10.1002/ijc.25242;
RA   Capes-Davis A., Theodosopoulos G., Atkin I., Drexler H.G., Kohara A.,
RA   MacLeod R.A.F., Masters J.R.W., Nakamura Y., Reid Y.A., Reddel R.R.,
RA   Freshney R.I.;
RT   "Check your cultures! A list of cross-contaminated or misidentified
RT   cell lines.";
RL   Int. J. Cancer 127:1-8(2010).
//